Trials / Sponsors / Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects Healthy Volunteer | Phase 1 | 2022-07-19 |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2022-04-08 |
| Active Not Recruiting | Atrasentan in Patients With IgA Nephropathy IgA Nephropathy, Immunoglobulin A Nephropathy | Phase 3 | 2020-12-11 |
| Terminated | Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM) Multiple Myeloma | Phase 1 / Phase 2 | 2017-11-15 |